COVID-19

A number of metrics are being examined by experts to determine how successful, or unsuccessful, the nation’s response to the coronavirus pandemic has been thus far.
For LSU Civil and Environmental Engineering Professor Brian Wolshon, that metric is traffic.

During a lecture on the Molecular & Cell Biology and Immunopathogenesis of coronaviruses attended virtually by more than 125 people, Konstantin “Gus” Kousoulas, head of the Department of Pathobiological Sciences at the LSU School of Veterinary Medicine, revealed that the drug Nelfinavir mesylate, or NFV, and brand name Viracept, holds exceptional promise in limiting COVID-19 infections. Viracept was developed as a protease inhibitor in the treatment of the human immunodeficiency virus, or HIV.

LSUE will hold a summer session and plans are moving forward for fall session.
While classes have moved online for the current session, the summer session is usually about 80% online, Chancellor Nancee Sorenson said.
The difference is science classes that have been moved online may return to the campus with the summer session, she said.
But the operative word is “maybe” The requirements such as social distancing put in place to slow the spread of CLOVID-19 are complicating planning.